While Novo Nordisk and Lilly are the undisputed leaders in weight management right now, a number of pharmaceutical companies ...

Novo Nordisk's stock has dropped to $110 per share, but operational performance remains strong. See why I believe we are at ...

Since its approval in mid-March of 2024, sales of Rezdiffra are increasing expediciously, reaching $62.2 million in Q3, the ...

Since then, Viking has reiterated this encouraging data from trials of the injectable candidate and reported favorable data ...

Analyst Michael Nedelcovych from TD Cowen maintained a Buy rating on Novo Nordisk (NVO – Research Report) and keeping the price target at ...

JPMorgan placed shares of Novo Nordisk (NVO) on “Positive Catalyst Watch” ahead of the CagriSema REDEFINE 1 obesity data. The ...

The reactions to Donald's Trump's victory across the crypto, currency, and stock markets. Super Micro's woes, and the outlook for a company with no auditor, no annual report and, perhaps soon, no ...

But that doesn't necessarily mean they want people to buy them. Partway through the Medicare annual ... (Cerullo, 11/13) The Hill: Ozempic And Wegovy May Help With Alcohol Addiction The weight loss ...

The tech company’s prices appear set to undercut the long list of competing telehealth companies that rely on aggressive ...

We recently published a list of 10 Best Stocks to Buy According to Billionaire Ken Fisher. In this article, we are going to ...

Shop Well+Good’s very first Good Deals event—a treasure trove of exclusive deals just in time for the holidays.